1 not yet recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Pembrolizumab and Irinotecan: new trials by email Literature Review of Pembrolizumab and Irinotecan trials Research Report on Pembrolizumab and Irinotecan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Combination Therapy With Pembrolizumab and Irinotecan in Patients With Metastatic or Recurrent Malignant Melanoma Pembrolizumab and Irinotecan - Unresectable or Metastatic Melanoma | Phase 1 / Phase 2 | Not yet recruiting | Yonsei University | 46 | 2026-11-01 | 2026-09-14 |
Melanoma (1)